Research ArticleOriginal Research

Blood Pressure Medication Side Effect Symptoms and Patient Treatment Satisfaction and Adherence

Karen L. Margolis, A. Lauren Crain, Pamala A. Pawloski, Jeanette Y. Ziegenfuss, Nicole K. Trower, Anna R. Bergdall, MarySue Beran, Christine K. Norton, Patricia K. Haugen, Daniel J. Rehrauer, Beverly B. Green, Leif I. Solberg and JoAnn M. Sperl-Hillen
The Journal of the American Board of Family Medicine March 2025, 38 (2) 312-329; DOI: https://doi.org/10.3122/jabfm.2024.240288R1

References

  1. 1.↵
    1. Muntner P,
    2. Miles MA,
    3. Jaeger BC,
    4. et al
    . Blood pressure control among US Adults, 2009 to 2012 through 2017 to 2020. Hypertension 2022;79:1971–80.
    OpenUrl
  2. 2.↵
    Million Hearts 2027. Blood pressure control. Division for Heart Disease and Stroke Prevention. Accessed January 10, 2024. Available at: https://millionhearts.hhs.gov/about-million-hearts/optimizing-care/bp-control.html.
  3. 3.↵
    1. Whelton PK,
    2. Carey RM,
    3. Aronow WS,
    4. et al
    . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018;71:1269–324.
    OpenUrlCrossRefPubMed
  4. 4.↵
    U.S. Department of Health and Human Services. The Surgeon General’s Call to Action to Control Hypertension. Washington, DC: U.S. Department of Health and Human Services, Office of the Surgeon General; 2020.
  5. 5.↵
    American Heart Association, American Medical Association. Target: BP. Accessed January 10, 2024. Available at: https://targetbp.org/.
  6. 6.↵
    National Hypertension Control Roundtable. Eliminating disparities in hypertension control through dialogue, partnership, evidence and innovation. Accessed January 10, 2024. Available at: https://hypertensioncontrol.org/.
  7. 7.↵
    1. Bellows BK,
    2. Ruiz-Negron N,
    3. Bibbins-Domingo K,
    4. et al
    . Clinic-based strategies to reach United States Million Hearts 2022 blood pressure control goals. Circ Cardiovasc Qual Outcomes 2019;12:e005624.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Poulter NR,
    2. Borghi C,
    3. Parati G,
    4. et al
    . Medication adherence in hypertension. J Hypertens 2020;38:579–87.
    OpenUrlPubMed
  9. 9.↵
    1. Fortuna RJ,
    2. Nagel AK,
    3. Rocco TA,
    4. Legette-Sobers S,
    5. Quigley DD
    . Patient experience with care and its association with adherence to hypertension medications. Am J Hypertens 2018;31:340–5.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Al-Ruthia YS,
    2. Hong SH,
    3. Graff C,
    4. Kocak M,
    5. Solomon D,
    6. Nolly R
    . Examining the relationship between antihypertensive medication satisfaction and adherence in older patients. Res Social Adm Pharm 2017;13:602–13.
    OpenUrlPubMed
  11. 11.↵
    1. Zyoud SH,
    2. Al-Jabi SW,
    3. Sweileh WM,
    4. Morisky DE
    . Relationship of treatment satisfaction to medication adherence: findings from a cross-sectional survey among hypertensive patients in Palestine. Health Qual Life Outcomes 2013;11:191.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Tedla YG,
    2. Bautista LE
    . Drug side effect symptoms and adherence to antihypertensive medication. Am J Hypertens 2016;29:772–9.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Bardage C,
    2. Isacson DG
    . Self-reported side-effects of antihypertensive drugs: an epidemiological study on prevalence and impact on health-state utility. Blood Press 2000;9:328–34.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Gandhi TK,
    2. Burstin HR,
    3. Cook EF,
    4. et al
    . Drug complications in outpatients. J Gen Intern Med 2000;15:149–54.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Margolis KL,
    2. Crain AL,
    3. Bergdall AR,
    4. et al
    . Design of a pragmatic cluster-randomized trial comparing telehealth care and best practice clinic-based care for uncontrolled high blood pressure. Contemp Clin Trials 2020;92:105939.
    OpenUrlPubMed
  16. 16.↵
    1. Ziegenfuss JY,
    2. Tillema J,
    3. Dean K,
    4. Kottke T
    . Cost and quality trade-offs in a well-being survey of HealthPartners patient members. Presented at: American Association for Public Opinion Research 70th Annual Conference 2015; Hollywood, FL.
  17. 17.↵
    1. Edwards P,
    2. Roberts I,
    3. Clarke M,
    4. et al
    . Methods to increase response rates to postal questionnaires. Review. Cochrane Database Syst Rev 2007;MR000008.
  18. 18.↵
    1. Dillman DA,
    2. Smyth JD,
    3. Christian LM
    . Internet, mail and mixed-mode surveys, the tailored design method 2014;528.
  19. 19.↵
    1. Duarte-Silva D,
    2. Figueiras A,
    3. Herdeiro MT,
    4. et al
    . PERSYVE - Design and validation of a questionnaire about adverse effects of antihypertensive drugs. Pharm Pract (Granada) 2014;12:396.
    OpenUrlPubMed
  20. 20.↵
    1. Atkinson MJ,
    2. Sinha A,
    3. Hass SL,
    4. et al
    . Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004;2:12.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Fowler F Jr.
    . Improving survey questions: design and evaluation 1995;38.
  22. 22.↵
    1. Frank L,
    2. Basch E,
    3. Selby JV
    , Patient-Centered Outcomes Research I. The PCORI perspective on patient-centered outcomes research. JAMA 2014;312:1513–4.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Cheung BM,
    2. Wong YL,
    3. Lau CP
    . Queen Mary utilization of antihypertensive drugs study: side-effects of antihypertensive drugs. J Clin Pharm Ther 2005;30:391–9.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Thomson JA,
    2. Wang WC,
    3. Browning C,
    4. Kendig HL
    . Self-reported medication side effects in an older cohort living independently in the community–the Melbourne Longitudinal Study on Healthy Ageing (MELSHA): cross-sectional analysis of prevalence and risk factors. BMC Geriatr 2010;10:37.
    OpenUrlPubMed
  25. 25.↵
    The treatment of mild hypertension study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. The Treatment of Mild Hypertension Research Group. Arch Intern Med 1991;151:1413–23.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Lewis CE,
    2. Grandits A,
    3. Flack J,
    4. McDonald R,
    5. Elmer PJ
    . Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension. Results of the Treatment of Mild Hypertension Study. Arch Intern Med 1996;156:377–85.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Solberg LI,
    2. Crain AL,
    3. Green BB,
    4. et al
    . Experiences and perceptions of patients with uncontrolled hypertension who are dissatisfied with their hypertension care. J Am Board Fam Med 2021;34:1115–22.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Morisky DE,
    2. Green LW,
    3. Levine DM
    . Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67–74.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Ibrahim S,
    2. Nurmohamed NS,
    3. Collard D,
    4. et al
    . Association between self-rated medication adherence and adverse cardiovascular outcomes in patients with hypertension. J Am Heart Assoc 2023;12:e031418.
    OpenUrlPubMed
  30. 30.↵
    1. Margolis KL,
    2. Bergdall AR,
    3. Crain AL,
    4. et al
    . Comparing pharmacist-led telehealth care and clinic-based care for uncontrolled high blood pressure: the Hyperlink 3 Pragmatic Cluster-Randomized Trial. Hypertension 2022;79:2708–20.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords